BBHvsIGSB
VanEck Biotech ETF against iShares 1-5 Year Investment Grade Corporate Bond ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| BBH | IGSB | |
|---|---|---|
| Expense ratio | 0.35% | 0.040% |
| Assets | $483M | $23.3B |
| Net flow, 1 month | −$5M | +$135M |
| Net flow, 1 year | −$21M | +$2.6B |
| Return, YTD | +24.9% | -3.2% |
| Return, 1 year | +35.7% | -3.2% |
| Avg daily volume | 10K | 5.3M |
| Holdings | 26 | 3892 |
| Listed | Nov 23, 1999 | Jan 5, 2007 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS